Ina Nepstad

1.1k total citations · 1 hit paper
19 papers, 774 citations indexed

About

Ina Nepstad is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Ina Nepstad has authored 19 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Ina Nepstad's work include Acute Myeloid Leukemia Research (11 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Heat shock proteins research (3 papers). Ina Nepstad is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Heat shock proteins research (3 papers). Ina Nepstad collaborates with scholars based in Norway and United States. Ina Nepstad's co-authors include Håkon Reikvam, Kimberley Joanne Hatfield, Øystein Bruserud, Ida Sofie Grønningsæter, Annette K. Brenner, Aina‐Cathrine Øvergård, Sonal Patel, Audun Helge Nerland, Knut Anders Mosevoll and Tor Henrik Anderson Tvedt and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Signal Transduction and Targeted Therapy.

In The Last Decade

Ina Nepstad

19 papers receiving 768 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells

2020 228 citations Ina Nepstad, Kimberley Joanne Hatfield et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ina Nepstad Norway	15	413	319	180	119	110	19	774
Stephan Lobitz Germany	16	435 1.1×	214 0.7×	104 0.6×	85 0.7×	128 1.2×	34	822
Shangbin Yang United States	18	294 0.7×	211 0.7×	406 2.3×	126 1.1×	92 0.8×	36	864
Tomoko Yoshioka Japan	13	411 1.0×	165 0.5×	308 1.7×	306 2.6×	119 1.1×	47	988
Cynthia R. Giver United States	20	597 1.4×	525 1.6×	342 1.9×	257 2.2×	171 1.6×	49	1.2k
Nataša Tos̆ić Serbia	17	423 1.0×	250 0.8×	74 0.4×	65 0.5×	113 1.0×	66	803
Timo Siitonen Finland	16	229 0.6×	238 0.7×	74 0.4×	131 1.1×	36 0.3×	48	572
Yuh‐Ching Twu Taiwan	18	263 0.6×	269 0.8×	175 1.0×	56 0.5×	75 0.7×	36	737
Loris Zamai Italy	12	397 1.0×	94 0.3×	265 1.5×	96 0.8×	69 0.6×	19	743
Naomi Park United Kingdom	7	373 0.9×	353 1.1×	48 0.3×	56 0.5×	184 1.7×	11	761
Serdar Bedii Omay Türkiye	17	203 0.5×	149 0.5×	48 0.3×	138 1.2×	44 0.4×	41	611

Countries citing papers authored by Ina Nepstad

Since Specialization

Citations

This map shows the geographic impact of Ina Nepstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Nepstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Nepstad more than expected).

Fields of papers citing papers by Ina Nepstad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Nepstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Nepstad. The network helps show where Ina Nepstad may publish in the future.

Co-authorship network of co-authors of Ina Nepstad

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Nepstad. A scholar is included among the top collaborators of Ina Nepstad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Nepstad. Ina Nepstad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Nepstad, Ina, Kimberley Joanne Hatfield, Ida Sofie Grønningsæter, & Håkon Reikvam. (2020). The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells. International Journal of Molecular Sciences. 21(8). 2907–2907. 228 indexed citations breakdown →

Nepstad, Ina, Kimberley Joanne Hatfield, Ida Sofie Grønningsæter, et al.. (2019). Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells. Signal Transduction and Targeted Therapy. 4(1). 20–20. 56 indexed citations

Mosevoll, Knut Anders, et al.. (2018). Cytokines, Adhesion Molecules, and Matrix Metalloproteases as Predisposing, Diagnostic, and Prognostic Factors in Venous Thrombosis. Frontiers in Medicine. 5. 147–147. 49 indexed citations

Nepstad, Ina, Kimberley Joanne Hatfield, Elise Aasebø, et al.. (2018). Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic, and transcriptomic comparison. Expert Opinion on Therapeutic Targets. 22(7). 639–653. 14 indexed citations

Brenner, Annette K., Ina Nepstad, & Øystein Bruserud. (2017). Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular Mechanisms. Frontiers in Immunology. 8. 106–106. 67 indexed citations

Brenner, Annette K., Tor Henrik Anderson Tvedt, Ina Nepstad, et al.. (2017). Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism. Expert Opinion on Therapeutic Targets. 21(4). 357–369. 27 indexed citations

Tvedt, Tor Henrik Anderson, Ina Nepstad, & Øystein Bruserud. (2016). Antileukemic effects of midostaurin in acute myeloid leukemia – the possible importance of multikinase inhibition in leukemic as well as nonleukemic stromal cells. Expert Opinion on Investigational Drugs. 26(3). 343–355. 22 indexed citations

Reikvam, Håkon, Annette K. Brenner, Ina Nepstad, André Sulen, & Øystein Bruserud. (2014). Heat shock protein 70 – the next chaperone to target in the treatment of human acute myelogenous leukemia?. Expert Opinion on Therapeutic Targets. 18(8). 929–944. 7 indexed citations

Reikvam, Håkon, et al.. (2014). Connexin expression in human acute myeloid leukemia cells: Identification of patient subsets based on protein and global gene expression profiles. International Journal of Molecular Medicine. 35(3). 645–652. 9 indexed citations

10.

Bruserud, Øystein, et al.. (2014). STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia. Expert Review of Hematology. 8(1). 29–41. 37 indexed citations

11.

Nepstad, Ina, Håkon Reikvam, Geir Strandenes, et al.. (2014). Comparison of in vitro responses to fresh whole blood and reconstituted whole blood after collagen stimulation.. PubMed. 12(1). 50–5. 8 indexed citations

12.

Reikvam, Håkon, Ina Nepstad, Øystein Bruserud, & Kimberley Joanne Hatfield. (2013). Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells. Oncotarget. 4(6). 830–843. 42 indexed citations

13.

Nepstad, Ina, et al.. (2013). An Extended Study of Seroprevalence of Anti‐Anisakis simplex IgE Antibodies in Norwegian Blood Donors. Scandinavian Journal of Immunology. 79(1). 61–67. 22 indexed citations

14.

Reikvam, Håkon, Ina Nepstad, André Sulen, et al.. (2013). Increased antileukemic effects in human acute myeloid leukemia by combining HSP70 and HSP90 inhibitors. Expert Opinion on Investigational Drugs. 22(5). 551–563. 25 indexed citations

15.

Reikvam, Håkon, Kimberley Joanne Hatfield, Hanne Fredly, et al.. (2012). The angioregulatory cytokine network in human acute myeloid leukemia – from leukemogenesis via remission induction to stem cell transplantation. European Cytokine Network. 23(4). 140–153. 46 indexed citations

16.

Hustad, Steinar, et al.. (2012). The effects of selective serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates. Platelets. 23(4). 299–308. 16 indexed citations

17.

Tsykunova, Galina, Håkon Reikvam, Aymen Ahmed, et al.. (2012). Targeting of polo-like kinases and their cross talk with Aurora kinases – possible therapeutic strategies in human acute myeloid leukemia?. Expert Opinion on Investigational Drugs. 21(5). 587–603. 22 indexed citations

18.

Ryningen, Anita, Håkon Reikvam, Ina Nepstad, Kristin Paulsen Rye, & Øystein Bruserud. (2012). Inhibition of Mammalian Target of Rapamycin in Human Acute Myeloid Leukemia Cells Has Diverse Effects That Depend on the Environmental In Vitro Stress. PubMed. 2012. 1–10. 7 indexed citations

19.

Øvergård, Aina‐Cathrine, Ina Nepstad, Audun Helge Nerland, & Sonal Patel. (2011). Characterisation and expression analysis of the Atlantic halibut (Hippoglossus hippoglossus L.) cytokines: IL-1β, IL-6, IL-11, IL-12β and IFNγ. Molecular Biology Reports. 39(3). 2201–2213. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact